Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 42, 2012 - Issue 11
460
Views
10
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Impact of nonlinear midazolam pharmacokinetics on the magnitude of the midazolam-ketoconazole interaction in rats

, , , &
Pages 1058-1068 | Received 09 Feb 2012, Accepted 06 Apr 2012, Published online: 11 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Run Li, Qingqing Wang, Zihou Liu, Like Xie, Zhipeng Diao, Ying Peng, Guangji Wang & Jianguo Sun. (2023) Dose-dependent pharmacokinetics of midazolam in rats: influence of hepatic first-pass metabolism. Xenobiotica 53:3, pages 184-192.
Read now

Articles from other publishers (9)

Hong-can Ren, Yang Sai, Tao Chen, Chun Zhang, Lily Tang & Cheng-guang Yang. (2021) Predicting the Drug–Drug Interaction Mediated by CYP3A4 Inhibition: Method Development and Performance Evaluation. The AAPS Journal 24:1.
Crossref
Sara Batista Nascimento, Mariana Lima Nascimento, Joaquim Maurício Duarte‐Almeida, Flávio Martins Oliveira, Maria Carmo Vieira, João Máximo Siqueira, Frank Pereira Andrade, Isabela Costa César & Whocely Victor Castro. (2020) Validation of a HPLC method for quantification of midazolam in rat plasma: Application during a Maytenus ilicifolia –drug interaction study . Biomedical Chromatography 35:3.
Crossref
Aarti Sawant-Basak, R. Scott Obach, Angela Doran, Peter Lockwood, Klaas Schildknegt, Hongying Gao, Jessica Mancuso, Susanna Tse & Thomas A. Comery. (2018) Metabolism of a 5HT 6 Antagonist, 2-Methyl-1-(Phenylsulfonyl)-4-(Piperazin-1-yl)-1H-Benzo[d]imidazole (SAM-760): Impact of Sulfonamide Metabolism on Diminution of a Ketoconazole-Mediated Clinical Drug-Drug Interaction . Drug Metabolism and Disposition 46:7, pages 934-942.
Crossref
Loai Basheer, Keren Schultz, Merav Fichman & Zohar Kerem. (2015) Use of In Vitro and Predictive In Silico Models to Study the Inhibition of Cytochrome P4503A by Stilbenes. PLOS ONE 10:10, pages e0141061.
Crossref
Katsuhito Nagai, Sho Suzuki, Ayumi Yamamura & Hiroki Konishi. (2015) Change in pharmacokinetic behavior of intravenously administered midazolam due to increased CYP3A2 expression in rats treated with menthol. Biopharmaceutics & Drug Disposition 36:3, pages 174-182.
Crossref
Rowan A. Stringer, Eckhard Weber, Bruno Tigani, Paul Lavan, Stephen Medhurst & Bindi Sohal. (2014) 1-Aminobenzotriazole Modulates Oral Drug Pharmacokinetics through Cytochrome P450 Inhibition and Delay of Gastric Emptying in Rats. Drug Metabolism and Disposition 42:7, pages 1117-1124.
Crossref
Shinya Uchida, Shimako Tanaka & Noriyuki Namiki. (2014) Simultaneous and comprehensive in vivo analysis of cytochrome P450 activity by using a cocktail approach in rats . Biopharmaceutics & Drug Disposition 35:4, pages 228-236.
Crossref
Nathalie Rioux, Edith Bellavance, Serge Bourg, Michel Garneau, Maria D. Ribadeneira & Jianmin Duan. (2013) Assessment of CYP3A‐mediated drug–drug interaction potential for victim drugs using an in vivo rat model . Biopharmaceutics & Drug Disposition 34:7, pages 396-401.
Crossref
Xin Tian, Zhen-Yu Cheng, Han Jin, Jie Gao & Hai-Ling Qiao. (2013) Inhibitory Effects of Baicalin on the Expression and Activity of CYP3A Induce the Pharmacokinetic Changes of Midazolam in Rats. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.